Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the Un…
$4.47+3.95%
报价 2026-11-06
市值
$126.2M
EV
$159.4M
PE (TTM)
–
预期 PE (FY2026)
61.7x
52 周区间距高点 -51.7%
$4.30$9.26
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| DERMJourney Medical Corporation | $126.2M | +4.0% | +31.1% | 68.4% | – | – | – | |
| FENCFennec Pharmaceuticals Inc. | $344M | +4.5% | +47.4% | 92.2% | – | – | – | |
| OBIOOrchestra BioMed Holdings, Inc. | $341.4M | +1.1% | -54.3% | 99.3% | – | – | – | |
| OSUROraSure Technologies, Inc. | $237.3M | +2.1% | +4.4% | 41% | – | – | – | |
| RNACCartesian Therapeutics, Inc. | $227.8M | +11.1% | -70.0% | 100% | – | – | – | |
| IVAInventiva S.A. | $197.5M | +4.7% | – | -5,232.7% | – | – | – | |
| MDWDMediWound Ltd. | $184M | +6.9% | – | 19.2% | – | – | – | |
| OGIOrganigram Global Inc. | $123.6M | -5.7% | – | 39.2% | 2.6x | – | – | |
| HSDTTessera Defense and Homeland Security Inc | $112.7M | -8.1% | +3075.0% | 95.5% | – | – | – | |
| 同行中位数 | – | – | +4.4% | 66.6% | 2.6x | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。